Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1988 of 5804
-
Weekly shot shows promise for adult growth hormone deficiency in Long-Term trial
Disease control CompletedThis was a phase 3 open-label multicenter extension study designed to evaluate the long-term safety and efficacy of Lonapegsomatropin administered once-weekly. The study participants were adults (males and females) with confirmed growth hormone deficiency (GHD) having completed t…
Phase: PHASE3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Blood test strategy may spare kidney patients from unnecessary biopsies
Disease control CompletedThe investigator hypothesize that the combined use of (1) non-invasive biomarkers in peripheral blood predicting anti-donor immunological activation or quiescence (2) interactive and actionable data analytics delivered at the bedside will promote safe clinical follow-up of kidney…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Birch bark gel shows promise for healing radiation burns in breast cancer
Symptom relief CompletedThe purpose of this study is find out whether Oleogel-S10 is an effective treatment for radiation dermatitis when it is used in combination with a standard wound treatment cream called triamcinolone. Oleogel-S10 has shortened the healing time for other types of skin wounds such a…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Nurse video visits help cancer patients after hospital discharge
Symptom relief CompletedThis study is examining whether a care transition intervention, CONTINUUM (CONTINUity of care Under Management by video visits), consisting of a supportive care-focused video visit with an oncology nurse practitioner (NP) within three business days of hospital discharge, may impr…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Promising combo for tough breast cancer hits snag: trial ends early
Disease control TerminatedThe goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with nab-paclitaxel or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in participants with non-surgically removable locally adv…
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Bubble burst breakthrough: ultrasound may boost bile duct cancer therapy
Diagnosis CompletedThis phase II trial tests whether contrast-enhanced ultrasound can predict the response of bile duct cancer to targeted radiotherapy (radioembolization treatment). Contrast-enhanced ultrasound uses gas microbubbles that may provide enhancement on ultrasound. It is also possible t…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Can a drug combo help smokers ditch cigarettes for E-Cigs?
Disease control CompletedThis three-group randomized double-blind placebo-controlled trial (N=180) will evaluate the impact of combination zonisamide and bupropion on the process of switching from combustible cigarettes (CCs) to an e-cigarette. There will be a data collection period of at least five days…
Phase: PHASE3 • Sponsor: Rose Research Center, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could one drug replace two after a heart attack stent?
Disease control CompletedA pilot study planned to evaluate initial safety of ticagrelor monotherapy after coronary stenting due to acute myocardial infarction. The study is a single-centre, single-arm, prospective phase II study 200 patients who undergo coronary artery stenting due to NSTEMI or STEMI wi…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Scientists track rare ataxia to unlock future treatments
Knowledge-focused Recruiting nowThis international, multi-center, multi-modal and prospective observational study aims to determine the phenotypic spectrum and the natural progression of the RFC1 repeat expansion disease, and to seek and validate digital, imaging, and molecular biomarkers that aid in diagnosis …
Sponsor: Prof. Dr. Matthis Synofzik • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New depression pill shows promise in large trial
Symptom relief Recruiting nowThis is a phase 2 and 3 adaptive design study for Mitizodone Phosphate,to find out an optimal dose in phase 2 period and confirm the result an efficacy and safety in phase 3 period.Dose-finding will be done after 8 weeks of double-blinded treatment in phase 2 period and will be a…
Phase: PHASE2, PHASE3 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Absorbable chest scaffold aims to reshape sunken sternum without metal
Disease control CompletedThe clinical study is testing a new treatment for pectus excavatum called "custom-made 3D printed scaffold-based soft tissue reconstruction". The new method uses a combination of the patients own adipocytes (fat cells) with a 3D printed scaffold (PCL Pectus Scaffold) to support s…
Phase: NA • Sponsor: BellaSeno Pty Ltd • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a custom mindfulness program ease chronic back pain?
Symptom relief CompletedThis is a development study with clinical outcomes. The investigators aim to develop and test an 8-week MBPR (Mindfulness-Based Pain Reduction) program, which draws on intervention work and clinical experience in the investigative team to optimize a mindfulness-based intervention…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could a new drug finally silence chronic cough?
Symptom relief CompletedCough is the most common presenting symptom to family physician. Chronic Cough affects approximately 10-12% of the general population and is one of the commonest reasons for referral to secondary care. Unfortunately, there are no licensed treatments for this debilitating conditio…
Phase: PHASE4 • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 26, 2026 17:49 UTC
-
Poop pills take on pancreatic cancer: early trial tests gut bacteria therapy
Disease control TerminatedThis early phase I trial examines the safety and effects of fecal microbial transplants in treating patients with pancreatic cancer. scheduled for surgery to remove tumors. Fecal microbial transplant contains the normal microbes found in fecal (stool) material. Giving fecal micro…
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Experimental cancer drug GEN1047 tested in humans – study halted early
Disease control TerminatedThe purpose of this trial is to measure the following in participants with solid tumors who receive GEN1047: * The side effects seen with GEN1047 * What the body does with GEN1047 once it is administered * What GEN1047 does to the body once it is administered * How well GEN1047 …
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a bladder drug and an ED drug fix prediabetes?
Disease control Recruiting nowThe investigator hypothesizes that treatment with the ß3 agonist mirabegron results in improved glucose metabolism, including a reversal of prediabetes in obese, insulin-resistant human research participants, and this is further improved by combination therapy with tadalafil. The…
Phase: PHASE4 • Sponsor: Philip Kern • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a simple program boost life satisfaction for those with mild cognitive impairment?
Symptom relief CompletedThe investigators developed and tested the Daily Engagement in Meaningful Activities (DEMA) intervention to improve life satisfaction and health outcomes for patients and caregivers. DEMA is a positive health focused, theoretically grounded, tailored, family-centered, multi-facet…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New light therapy could zap stubborn acne without pills
Disease control CompletedThe aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) for the medication Ameluz® performed with the PDT-lamp BF-RhodoLED® in comparison to the respective placebo treatment for moderate to severe Acne vulgaris.
Phase: PHASE2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug hope for rare sarcomas after chemo fails
Disease control OngoingThe purpose is to evaluate the effectiveness and safety of Surufatinib in patients with osteosarcoma and soft tissue sarcoma after Standard chemotherapy therapy.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control TerminatedAn investigation of the safety and efficacy of tildacerfont in participants with CAH.
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC